Annexin A9 Antibodies

Santa Cruz Biotechnology delivers a wide array of Annexin A9 monoclonal antibodies for investigating Annexin A9's role in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Annexin A9 belongs to the annexin family, which plays essential roles in cellular processes such as apoptosis, membrane trafficking, and inflammation. Annexin A9 significantly influences cell death and survival mechanisms, making it a key focus in cancer research and other disease studies. Research focused on Annexin A9 continues to reveal new insights into pathological conditions and potential therapeutic strategies. Scientists worldwide rely on Annexin A9 monoclonal antibodies to advance their understanding of cellular mechanisms. Ongoing studies of Annexin A9 contribute to the development of novel therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers to generate reliable, reproducible results that advance scientific knowledge.